Prevalence, Awareness, Attitudes and Patterns of Stimulant Drug Use Among Students in Egyptian Universities
SDU
Prevalence, Patterns, Awareness and Attitudes of Stimulant Drug Use Among Students in Egyptian Universities: a Cross-sectional Study.
1 other identifier
observational
1,500
1 country
1
Brief Summary
Stimulants are dangerous drugs that are commonly abused by individuals looking to stay alert and focused, lose weight, stay awake, and get high. Although these drugs can be extremely harmful and even life-threatening, many of them can also be used to treat conditions like ADHD, narcolepsy, and in some cases, depression. There are many types of stimulant drugs, and it can be beneficial to know a little about each one, its purposes, and how harmful it can be when abused. Illicit stimulants are usually schedule II, depending on whether or not they can be used to treat medical conditions. While some variations of stimulants are schedule I drugs, most are extremely addictive and dangerous schedule II substances. These drugs are often abused in a binge-crash pattern. According to the NIDA Teen, "In order to keep the 'high' going, people may take the drug repeatedly within a short period of time, at increasingly higher doses." This makes these drugs extremely addictive. The aim of this survey to detect prevalence of non prescription stimulants in Egyptian students and increase their awareness of the harmful effects of these drugs.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 9, 2024
CompletedFirst Posted
Study publicly available on registry
October 17, 2024
CompletedStudy Start
First participant enrolled
December 10, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2025
CompletedOctober 2, 2025
October 1, 2024
5 months
October 9, 2024
September 27, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Prevalence/ pattern
* \- Do/ did you use stimulants ( Recreational drugs): Yes No * How do / did you obtain this medication Prescribed Non prescribed * When did you start receiving stimulants for last 1 year for last 3 years for last 5 years * Which Stimulant (drug) is/ was used * tobacco products (e.g., coffee, chocolate, cigarettes) high caffeine products * pseudoephedrine, ( nasal decongestant) * methylphenidate \[Ritalin\] * amphetamine \[Adderall\] * methamphetamine * modafinil (Provigil) * dextroamphetamine (Dexedrine) * dextro/levoamphetamine (Adderall) * adrafinil (Olmifon) * piracetam * Others
1 year
Awareness/ attitude
\- How do you know about the effect of stimulants: Substance use by peers Friends as a source of prescription stimulants Social media Promotion * Why do you use stimulant Because it helps me concentrate Because it helps me study and enhance memory Because it helps increase my alertness and concentration Because it gives me a high mood Because it helps me to be more energetic Because it improves sleep quality Because it decreases stress level Because of experimentation Because it helps me lose weight * Do you know that stimulant is harmful to the body systems Yes No * Which of the following side effects do you experience after using stimulant * decreased appetite * weight loss * headache * insomnia * dizziness * nervousness. * Seizures * cardiac events (increase blood pressure and heart rate, heart attacks) * psychosis * Did you receive treatment for the side effects after using stimulants Yes No
1 year
Secondary Outcomes (1)
Demographic data
1 year
Study Arms (1)
study group
Undergraduate students at a large public university in Egypt who were 18 years of age or older took the survey in 2024. All survey and recruitment materials were approved by Minia University, faculty of pharmacy. Students were received survey through email. Students took the survey online at a time and location of their choice.
Interventions
Eligibility Criteria
Undergraduate students at a large public university in Egypt who were 18 years of age or older took the survey in 2024. All survey and recruitment materials were approved by Minia University, faculty of pharmacy. Students were received survey through email. Students took the survey online at a time and location of their choice. No time limit was imposed.
You may qualify if:
- \- Academic student Age (18-30) years Included in medical faculty
You may not qualify if:
- Not undergraduates student Aged \< 18 years
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Asmaa Ahmed Hamed
Minya, 11666, Egypt
MeSH Terms
Conditions
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Associate professor
Study Record Dates
First Submitted
October 9, 2024
First Posted
October 17, 2024
Study Start
December 10, 2024
Primary Completion
April 30, 2025
Study Completion
November 30, 2025
Last Updated
October 2, 2025
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will not share